D
Dipti Agarwal
Researcher at Mayo Clinic
Publications - 48
Citations - 1023
Dipti Agarwal is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Medicine & Pneumothorax. The author has an hindex of 14, co-authored 41 publications receiving 916 citations. Previous affiliations of Dipti Agarwal include Genesis Health System.
Papers
More filters
Journal ArticleDOI
Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: A systematic review
Anant Mohan,Subhash Chandra,Dipti Agarwal,Randeep Guleria,Shobha Broor,Bharti Gaur,Ravindra Mohan Pandey +6 more
TL;DR: A systematic review calculated the prevalence of respiratory viral infections in AECOPD and found that viruses are important aetiological agents of acute exacerbation of COPD.
Journal ArticleDOI
Development of a clinical prediction rule for 30-day cardiac events in emergency department patients with chest pain and possible acute coronary syndrome
Erik P. Hess,Erik P. Hess,Robert J. Brison,Jeffrey J. Perry,Lisa A. Calder,Venkatesh Thiruganasambandamoorthy,Dipti Agarwal,Annie T. Sadosty,Marco L.A. Silvilotti,Allan S. Jaffe,Victor M. Montori,Victor M. Montori,George A. Wells,Ian G. Stiell +13 more
TL;DR: This clinical prediction rule identifies ED chest pain patients at very low risk for a cardiac event who may be suitable for discharge and is validated with 5,000 bootstrap replications.
Journal ArticleDOI
Diagnostic accuracy of the TIMI risk score in patients with chest pain in the emergency department: a meta-analysis
Erik P. Hess,Dipti Agarwal,Subhash Chandra,Mohammed H. Murad,Patricia J. Erwin,Judd E. Hollander,Victor M. Montori,Ian G. Stiell +7 more
TL;DR: Although the TIMI risk score is an effective risk stratification tool for patients in the emergency department with potential acute coronary syndromes, it should not be used as the sole means of determining patient disposition.
Journal ArticleDOI
Ventricular fibrillation in Rochester, Minnesota: experience over 18 years.
TL;DR: High survival from witnessed VF OHCA (46.3%) was achieved over 18 years in a medium-sized city incorporating an aggressive approach to OHCA, and rapid response, and therefore rapid defibrillation was the major contributor to survival.
Journal ArticleDOI
Diagnostic accuracy of endobronchial ultrasound-guided transbronchial needle biopsy in mediastinal lymphadenopathy: a systematic review and meta-analysis.
TL;DR: Evidence of moderate quality confirms the high diagnostic performance of EBUS-TBNB for mediastinal and hilar lymphadenopathy, both in malignant and non-malignant conditions.